LSI Stock Overview
An investment holding company, researches, develops, manufactures, commercializes, markets, and sells health and agriculture-related products in the Asia Pacific and North America. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
CK Life Sciences Int'l., (Holdings) Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.045 |
| 52 Week High | HK$0.067 |
| 52 Week Low | HK$0.032 |
| Beta | 0.033 |
| 1 Month Change | -6.25% |
| 3 Month Change | 18.42% |
| 1 Year Change | -31.82% |
| 3 Year Change | -43.04% |
| 5 Year Change | -54.55% |
| Change since IPO | -28.57% |
Recent News & Updates
Recent updates
Shareholder Returns
| LSI | DE Biotechs | DE Market | |
|---|---|---|---|
| 7D | 2.3% | 3.1% | 0.5% |
| 1Y | -31.8% | -13.8% | 7.2% |
Return vs Industry: LSI underperformed the German Biotechs industry which returned -14.5% over the past year.
Return vs Market: LSI underperformed the German Market which returned 7% over the past year.
Price Volatility
| LSI volatility | |
|---|---|
| LSI Average Weekly Movement | 9.1% |
| Biotechs Industry Average Movement | 7.0% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.5% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: LSI's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: LSI's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 1,968 | Lance Richard Lee Yuen | www.ck-lifesciences.com |
CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, markets, and sells health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, and sells fertilizers, pesticides, and related agricultural products; manufactures and distributes horticultural products for the home gardening market; and produces non-sterile prescription and over-the-counter medicines. The company is also involved in the contract manufacturing of complementary healthcare medicines, pharmaceutical products, and cosmetics; licensing of registration activities and the importation of finished agricultural goods; holding of land and buildings; financing activities; investment in financial instruments and vineyards; trading of biotechnology products and nutritional supplements; and manufacturing, wholesaling, retailing, and distribution of nutraceutical products.
CK Life Sciences Int'l., (Holdings) Inc. Fundamentals Summary
| LSI fundamental statistics | |
|---|---|
| Market cap | €486.90m |
| Earnings (TTM) | -€2.31m |
| Revenue (TTM) | €664.69m |
0.7x
P/S Ratio-211.2x
P/E RatioIs LSI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LSI income statement (TTM) | |
|---|---|
| Revenue | HK$5.38b |
| Cost of Revenue | HK$3.74b |
| Gross Profit | HK$1.64b |
| Other Expenses | HK$1.66b |
| Earnings | -HK$18.66m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0019 |
| Gross Margin | 30.43% |
| Net Profit Margin | -0.35% |
| Debt/Equity Ratio | 136.3% |
How did LSI perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/27 12:04 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
CK Life Sciences Int'l., (Holdings) Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jayaprabha Dhavale | Virtua Research Inc. |